Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) FCF Margin (2024 - 2026)

Camp4 Therapeutics' FCF Margin history spans 2 years, with the latest figure at 1795.11% for Q4 2025.

  • On a quarterly basis, FCF Margin rose 349910.0% to 1795.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 852.83%, a 613521.0% increase, with the full-year FY2025 number at 852.83%, up 613521.0% from a year prior.
  • FCF Margin hit 1795.11% in Q4 2025 for Camp4 Therapeutics, up from 1408.81% in the prior quarter.
  • Over the last five years, FCF Margin for CAMP hit a ceiling of 1795.11% in Q4 2025 and a floor of 1703.99% in Q4 2024.